Orna Therapeutics, Inc. is a company headquartered in Cambridge, MA. The firm develops mRNA therapeutics. It was founded by Alex Wesselhoeft, Raffaella Squilloni and Daniel Anderson. Thomas M. Barnes is currently the CEO of the company.\nThe company says this about itself: Orna Therapeutics was founded on groundbreaking research by Alex Wesselhoeft, Ph.D., and Daniel G. Anderson, Ph.D. from MIT and built by MPM Capital and BioImpact Capital, an investment management affiliate of MPM. Orna’s proprietary circular RNA (oRNA) is engineered as linear RNA that self-circularizes. By taking a line and turning it into a circle, oRNA exhibits numerous advantages over traditional linear mRNA therapies such as simplified production, increased protein expression, and a superior immunogenicity profile. With proprietary lipid nanoparticles (LNPs), including those from Orna’s joint venture with ReNAgade Therapeutics, an RNA delivery company, our technologies expand the possibilities of what RNA therapeutics can achieve.

Riken Corp. engages in the manufacture and sale of engine and vehicular components. It operates through the Automotive and Machinery Parts, and Others segments. The Automotive and Machinery Parts segment deals with the company's core products such as piston rings, camshafts, seal rings for transmissions, high-grade cast iron products, and valve lifters. The Others segment includes plumbing equipment business, Electromagnetic Compatibility (EMC) business, and thermal engineering business, The company was founded by Masatoshi Okochi in November 1927 and is headquartered in Tokyo, Japan.

Otsuka Holdings operates in pharmaceuticals, nutraceuticals, and consumer products. The business activity of the company includes providing healthcare solutions in the areas of the nervous system, oncology, cardiovascular system, respiratory system, infectious disease, and others. The company engages in the research and development of functional foods and beverages, such as electrolyte drinks, nutritional foods, soy snacks, and dietary foods.

Evox Therapeutics is a privately held, Oxford-based biotechnology company focused on harnessing and engineering the natural delivery capabilities of extracellular vesicles, known as exosomes, to develop an entirely new class of therapeutics. Backed by leading Life Sciences Venture Capital groups and supported by a comprehensive intellectual property portfolio, Evox’s mission is to positively impact human health by creating novel exosome-based therapeutics for the treatment of various severe diseases with limited options for patients and their families. Evox has created substantial proprietary technology to modify exosomes using various molecular engineering, drug loading, and targeting strategies to facilitate targeted drug delivery to organs of interest, including the brain and the central nervous system. Exosome-based drugs have the potential to address some of the limitations of protein, antibody and nucleic acid-based therapies by enabling delivery to cells and tissues that are currently out of reach using other drug delivery technologies. Evox is leading the development within this emerging therapeutic space.

Guangzhou Yongnuo Biotechnology Co., Ltd., established on 2010-12-03, Business scope includes medical equipment rental services;Biotechnology Extension Services;Patent Service;Information Technology Consulting Services;Biotechnology Development Services;General Equipment Repair;Medical Research and Experimental Development;Instrument Repair;Science and Technology Information Consulting Services;drug development;Biotechnology Consulting,communication service;translation service;Medical Equipment Repair;Import and export(Excluding franchised products);Biotechnology Transfer Services;Natural science research and experimental development;Business Management Consulting Services;Commodity retail trade(Except for licensed and approved products);Technology Import and Export;Data Processing and Storage Services;Nutrition and Health Consulting Services;Commodity wholesale trade(Except for licensed and approved products);Research and development of biological products(Does not include licensed operations);Research and development of biodiagnostic reagents and kits(Does not include license approval items);Operation of non-licensed medical devices;Sales of products produced by the company(Except for projects prohibited by national laws and regulations;Products involving licensed operation need to obtain a license before they can be operated);Sales of biological diagnostic reagents and kits(Does not include license approval items);Sales of Biological Products(Does not include licensed operations);Technology intermediary service;Corporate Image Planning Service;medical diagnosis,Monitoring and treatment equipment retail;medical diagnosis,Monitoring and treatment equipment wholesale;Licensed medical device business;

Guangzhou Jisai Biotechnology Co., Ltd., established on 2010-06-08, The scope of business includes the manufacture of special equipment for teaching;Health Sciences Program Research,to develop;Medical Research and Experimental Development;Gene drug development;Stem Cell Technology Research,to develop;Natural science research and experimental development;Human Science Research,to develop;Instrument wholesale;Commodity wholesale trade(Except for licensed and approved products);Wholesale of chemical products(Excluding hazardous chemicals);Biotechnology Consulting,communication service;Biotechnology Development Services;Biotechnology Transfer Services;Biotechnology Extension Services;Engineering and Technology Research and Experimental Development;Manufacturing of experimental analysis instruments;Chemical Reagent and Auxiliary Manufacturing(Monitor Chemicals,Excluding hazardous chemicals);New material technology development service;New material technical consultation,communication service;New material technology transfer service;trade agent;Commodity retail trade(Except for licensed and approved products);Trade Advisory Services;Import and export(Excluding franchised products);Technology Import and Export

Shanghai Institutes for Biological Sciences CAS is a private company headquartered in Shanghai, China, that operates as researching agency.

Suzhou Cremed Biomedical Technology Co., Ltd., established on 2021-08-18, Business scope includes licensed projects:Inspection and testing service;Import and export;Technology Import and Export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:R&D and application of cell technology;Medical Research and Experimental Development;Research and development of bio-based materials technology;Sales of bio-based materials;Sales of Class I Medical Devices;Sales of Class II Medical Devices;New material technology research and development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Experimental analysis instrument sales(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Hayashi Kasei Co., Ltd. manufactures and supplies industrial chemicals. Its products include talc, kaolin, wollastonite and appapulgite, ground calcium carbonate and diatomaceous earth. The company was founded in January 1919 and is headquartered in Osaka, Japan.

Cofactor Genomics is a Predictive Immune Modeling company driven to remove the barriers that have prohibited the advancement of true precision medicine. Cofactor is enabling the industry to move beyond isolated, single-analyte biomarkers to powerful multidimensional biomarkers using Health Expression Models. Through their molecular, informatic, and database tools, and one of the first CAP-certified, clinical RNA sequencing laboratories, Cofactor enables their partners to deliver more expedient, cost-effective, and successful clinical trials.

SomaGenics, Inc. is a private company headquartered in Santa Cruz, CA, that operates as a biotechnology company.\nThe company says this about itself: SomaGenics, Inc. is a privately held company with offices and laboratories located in Santa Cruz, California. We specialize in developing novel RNA-centered approaches to address unmet life science research and medical needs. Our core competencies include RNA molecules as therapeutic agents, drug targets and biomarkers as well as the development of innovative kits for RNA analysis.

Beijing Qichensheng Biotechnology Co., Ltd., established on 2015-12-15, The scope of business includes engaging in biomedicine,Technology development of biological detection and treatment technology,Technical Services,technical consulting,technology transfer,Technical Training;Sales of chemical products,chemical reagent,Instrumentation,Ι class medical device;Technology Import and Export;Conference Services;Undertake exhibition and display activities.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Nanjing Millennium Health Stem Cell Genetic Engineering Co., Ltd., established on 2016-09-28, Business scope includes stem cell biotechnology development,technology transfer,technical consulting,Technical Services;Immune Cell Technology Development,technology transfer,technical consulting,Technical Services;Genetic testing technology development,technology transfer,technical consulting,Technical Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Zhenjiang First People's Hospital is a Chinese private company located in Zhenjiang that provides healthcare services.

Roche Diagnostics GmbH, part of Roche Holding AG, is a company headquartered in Mannheim, Germany, involved in laboratory analytical instruments. Andreas Schmitz and Claus Haberda are the current co-CEOs of the firm. On January 01, 1999 Roche Holding AG acquired Roche Diagnostics GmbH.

West China Second University Hospital is a Chinese private company located in Chengdu. The firm provides women and children healthcare services.